Waldencast plc operates in the beauty and wellness industry in the United States, Canada, Europe, the Middle East, India, Australia, and New Zealand. The compan...
Waldencast completes sale of Obagi Medical to Bridgepoint valued up to $460 million
Croma-Pharma Announces FDA Approval of Obagi saypha® ChIQ™ in the United States
June 2026's Promising Penny Stocks To Watch
Waldencast shares are trading higher after the company announced that it will sell its Obagi Medical unit to Bridgepoint for as much as $460M
12 Consumer Staples Stocks Moving In Monday's Pre-Market Session
Obagi Medical Shares New Data on Recent Innovations at Music City Symposium for Cosmetic Advances & Laser Education (SCALE) Meeting | WALD Stock News